Early IV Magnesium for Moderate Asthma in Children
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests whether giving magnesium sulfate through an IV early in the emergency room helps children aged 5–17 who are having a moderate asthma attack. It aims to improve breathing and reduce the need for hospital stays.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 5 and 17 years old
- Be having a moderate asthma attack (not mild or severe)
- Have a parent or caregiver who speaks English
- Not have other serious health conditions like chronic lung disease, cerebral palsy, or heart problems
- Not be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if giving magnesium sulfate (a mineral supplement) helps children with asthma or bronchiolitis breathe better. It is for children aged 1 month to under 18 years who have these conditions.
This trial tests if giving magnesium sulfate through an IV helps children with moderate to severe asthma attacks in the emergency department. If your child is between 2 and 17 years old and still has trouble breathing after three puffs of standard asthma medicine, this study may be an option.
This trial tests whether giving a higher dose of magnesium (given as an IV drip) works better than the standard dose for treating a severe asthma attack in the emergency room. It aims to see if the higher dose helps you breathe easier sooner.
This trial tests whether giving magnesium as part of a standard hospital protocol can lower the risk of irregular heartbeat and improve survival in patients admitted to the intensive care unit.
This trial tests whether giving magnesium sulphate to newborns with birth asphyxia (lack of oxygen at birth) can help them recover faster and shorten their hospital stay.
This trial tests whether giving magnesium sulfate through a vein in the emergency room can reduce sudden (non-injury) acute headaches compared with a placebo. It may help people whose headache comes on suddenly and is not caused by an injury.
Hear when a new Asthma in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.